Photo via BBC News

US Health Secretary RFK Jr to expand access to unapproved peptides

Read the original at BBC News ↗
Cite

Habeshian, S. (2026, October 29). US Health Secretary RFK Jr to expand access to unapproved peptides. BBC News. https://www.bbc.co.uk/news/articles/cmq8nwd748v3o?at_medium=RSS&at_campaign=rss

Dated from the outlet's own feed. Check the original for its byline.

BBC News · collected 2026-10-29 · by Sareen Habeshian

Quick Summary

US Health Secretary Robert F Kennedy Jr has announced plans to relax restrictions on six unapproved peptides through compounding pharmacies, despite warnings from health experts about their potential risks due to insufficient human clinical trials and unknown long-term side effects. The draft regulation was published in the US Federal Register and will undergo a public comment period following its official publication later this week. The FDA's advisory panel had voted earlier to loosen restrictions on these peptides but FDA staff recommended against it, highlighting the controversy surrounding their use.
Written by AI on 2026-10-29, from this article's own text only (the story summary below draws on all the coverage).
See how they differ ↓

AI analysis

Story summary

As of October 28, 2026, the Trump administration's Department of Health and Human Services (HHS) allowed pharmacies to produce and sell six unapproved peptide drugs without FDA approval. This decision faced significant opposition from most FDA scientific staff members who warned it could undermine public health by exposing Americans to potentially unsafe substances. HHS stated that this move is intended to provide a regulated alternative for consumers seeking peptides, which have previously been available through the "gray market," often imported illegally from countries like China. The policy will be in effect while HHS works on formalizing a rule change and is set to take comments for two weeks before finalization.

Written for “RFK Jr Eases Access To Unapproved Peptides” on 2026-11-21, grounded in this article and the 13 other(s) covering the same event.

How they differ

11 outlets covered “RFK Jr Eases Access To Unapproved Peptides”.

What each outlet says

One AI summary per outlet of its latest article on this story, written from that article alone and checked against it. Open the article for the outlet's own words.

BBCThis outlet29 Oct

US Health Secretary Robert F Kennedy Jr has announced plans to relax restrictions on six unapproved peptides through compounding pharmacies, despite warnings from health experts about their potential risks due to insufficient human clinical trials and unknown long-term side effects. The draft regulation was published in the US Federal Register and will undergo a public comment period following its official…

US Health Secretary RFK Jr to expand access to unapproved peptides (this article)
CBS News29 Oct

Adam Yamaguchi reports on Robert F. Kennedy Jr.’s efforts to encourage pharmacies to manufacture peptides that have not been approved by the FDA. The article focuses specifically on RFK Jr.’s advocacy for these unregulated substances, which are being promoted despite lacking official approval from regulatory authorities.

Inside RFK Jr.'s push for pharmacies to make non-FDA approved peptides →3 articles from CBS News on this story
ABC News (US)29 Oct

HHS announced that some wellness peptides will be available by prescription. The department will temporarily allow compounding pharmacies to provide six specific peptides through prescriptions. This announcement was made on October 29, 2026.

WATCH: HHS says some wellness peptides will be available by prescription →2 articles from ABC News (US) on this story
NBC News28 Oct

The Department of Health and Human Services has temporarily allowed compounding pharmacies to manufacture six unapproved peptides without legal repercussions while the FDA formalizes new rules for their production. These peptides include BPC-157, epitalon, KPV, MOTS-c, semax, and TB-500, which are marketed as treatments for various health conditions but lack FDA approval due to insufficient safety and efficacy data…

RFK Jr. takes shortcut to make some peptides more widely available →
Toronto Star28 Oct

FDA scientific staff largely opposed a Trump administration plan aimed at easing access to unproven peptide drugs, despite pushback from Health Secretary Robert F. Kennedy Jr. This policy would allow specialty pharmacies to sell peptides without the FDA's rigorous safety and effectiveness review process, which are currently considered illegal drugs. Most FDA drug staffers warned that this could undermine the…

FDA scientists opposed the Trump administration's move to ease peptides access →
The Guardian28 Oct

FDA scientific staff members opposed a Trump administration plan pushed by Health Secretary Robert F Kennedy Jr, which aimed to ease access to unproven peptide drugs in the US wellness industry. The policy, posted online by HHS on Wednesday, would allow specialty pharmacies to sell several peptides without FDA approval, despite warnings from FDA scientists about potential safety risks. This move faces significant…

FDA scientists opposed Trump administration’s move to ease peptide access →
Show 5 more outlets
Time28 Oct

The U.S. Department of Health and Human Services announced on October 28 that it will not take enforcement action against licensed pharmacists who dispense six unapproved peptides to consumers. These peptides include BPC-157, Epitalon, KPV, MOTS-c, Semax, and TB-500, which are short chains of amino acids injected for various health benefits, despite scientific uncertainty about their safety and efficacy. The policy…

The Peptide Rush Has Begun →
NPR29 Oct

The Trump administration's Department of Health and Human Services plans to relax restrictions on six unproven peptides, allowing small compounding pharmacies to produce them despite lacking FDA approval. This policy change supports wellness influencers and some clinicians who promote these peptides for various health issues like ulcerative colitis and insomnia, though evidence of their safety and effectiveness is…

Trump administration will allow pharmacies to make popular peptides →
The Independent29 Oct

Health Secretary Robert F. Kennedy Jr. announced a new policy allowing the widespread use of six unapproved peptide compounds, despite the FDA advising against their use due to potential risks. The Health and Human Services Department will not take enforcement action against those selling these peptides, arguing that easing access will provide patients with controlled alternatives while protecting safety through…

RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them →
Reason29 Oct

HHS has established a new policy allowing pharmacies to produce and sell six specific peptides without FDA approval, aiming to provide a safer alternative to purchasing these substances from unregulated foreign sources. The decision is seen as a victory for peptide advocates and reflects frustration with FDA's slow processes, despite the lack of formal FDA endorsement or safety reviews for compounded drugs.

RFK Jr. Institutes Backdoor Approval of 6 Peptides →
New York Post29 Oct

The Trump administration recently relaxed regulations to allow easier access to unproven peptide drugs favored by Health Secretary Robert F. Kennedy Jr., despite opposition from the FDA’s scientific staff. The Department of Health and Human Services draft policy targets specific peptides used for wellness purposes such as muscle building and injury healing, allowing specialty pharmacies to sell them without facing…

Trump admin eases access to unproven peptides favored by RFK Jr. despite FDA opposition →

Where they agree and split

Framing

How the first headlines put it

Attributed to a source2
Stated as fact7
The headlines (9)

Some wellness peptides will become widely available, HHS says ABC News · attributed to a source

RFK Jr says he will allow widespread unapproved injections despite his FDA advising people not to use them The Independent · attributed to a source

RFK Jr. takes shortcut to make some peptides more widely available NBC News · stated as fact

FDA scientists opposed the Trump administration's move to ease peptides access Toronto Star · stated as fact

FDA scientists opposed Trump administration’s move to ease peptide access The Guardian · stated as fact

The Peptide Rush Has Begun Time · stated as fact

Trump administration will allow pharmacies to make popular peptides NPR · stated as fact

Dr. Jon LaPook explains why peptide sales are controversial CBS News · stated as fact

US Health Secretary RFK Jr to expand access to unapproved peptides BBC · stated as fact

The full story: what happened, how it changed, and all 14 articles →

Compared with similar articles

This article reads leans right and hedges 5% of its claims. Each row says how that neighbour differs.
CBS News
Hedges 0 of 1 claims Outlet record 66/100
New York Post
Hedges 6 of 46 claims Outlet record 66/100
NBC News
Hedges 4 of 19 claims Outlet record 74/100
NPR
Leans right Hedges 4 of 30 claims Outlet record 60/100
CBS News
Centre further left than this Hedges 1 of 3 claims Outlet record 66/100
CBS News
Hedges 3 of 22 claims Outlet record 66/100
The Independent
Hedges 1 of 12 claims Outlet record 59/100
Reason
Hedges 5 of 23 claims Outlet record 67/100
The Guardian
Leans left further left than this Hedges 4 of 30 claims Outlet record 64/100
TIME
Hedges 3 of 28 claims Outlet record 60/100

Story

RFK Jr Eases Access To Unapproved Peptides
Politics · 14 article(s) covering the same event. Compare every outlet's account →
How this article was measured signals, leaning charts, publisher record, byline, topics and claims

Signals How these are calculated →

Claims extracted
20
sentences that state something as happening or true
Uncertain
5%
1 of 20 hedged ("reportedly", "may", "according to")
Leaning
Leans right
of the writing, not the subject · beta estimate
Publisher signals
65/100
BBC News's corrections and hedging, across everything collected from it. Not a measure of accuracy.
Outlets on this story
14
Politics
Same framing elsewhere
1
articles that frame the event the way this one does
Analyzed 2026-10-29 · how these are computed

How this is being covered How these are calculated →

Article leaning vs. publisher reliability
Source leaning vs. consistency

Publisher

BBC News · 6387 article(s) · 9 correction(s) detected
Running correction rate · 9 correction(s)

Who wrote this

Sareen Habeshian
40 article(s) here · 1 carrying a prediction
Trump also said on Thursday that Rose's "record of 4,256 Hits in a Season will never be broken".
2026-11-20 · assertive framing · Trump posthumously pardons US baseball legend Pete Rose
The vet staff "tried everything they could to help her" but "it was ultimately too much to overcome", the zoo said.
This will be the first 007 not under creative control of the Broccoli family, who has overseen the franchise since its start in 1962.
The NTSB said there are many different things that could be classified as a steering casualty, and they are "looking at all of them".
A BBC spokesperson said: "We are surprised by this decision but respect the Court's authority and note the case will now proceed to the next stage."
The ballot proposal would have levied a one-time tax on the state's mega wealthy to help fund healthcare.
2026-11-10 · assertive framing · Californians reject wealth tax for billionaires
- Published The mayor of Houston, Texas, has directed the city's police to limit co-operation with federal immigration officials.
- Published The White House has denied rumours that Defence Secretary Pete Hegseth and Secretary of State Marco Rubio might leave their jobs in a post-election shakeup of the Trump administration.
The justice department wanted 20,000 ballots to be set aside that it alleged may have been issued to non-US citizens in the state.
It comes ahead of the US midterm elections, which will determine whether the Republicans or Democrats control Congress.
2026-11-03 · assertive framing · US strikes Iran ahead of midterm elections
Also by Sareen Habeshian
Nothing else under this byline is closely related to this article, so these are simply their most recent.
All 40 articles by Sareen Habeshian →

Topics

FDA Federal Register Health Semax the Food and Drug Administration

Subjects

FDA ORG · 5× Kennedy PERSON · 2× BBC ORG · 1× Biden PERSON · 1× Federal Register ORG · 1× Health ORG · 1× Robert F Kennedy Jr. PERSON · 1× TikTok ORG · 1× the Food and Drug Administration ORG · 1×

Narrative

The plans, which were announced in the US Federal Register on Wednesday, say Kennedy would allow compounding pharmacies to prepare six popular peptides, which not been approved by the Food and Drug Administration (FDA).
framing: assertive · carried by 1 article(s) · first seen 2026-10-29
The plans, which were announced in the US Federal Register on Wednesday, say Kennedy would allow compounding pharmacies to prepare six popular peptides, which not been approved by the Food and Drug Administration (FDA).
2026-10-29 · BBC News
US Health Secretary RFK Jr to expand access to unapproved peptides · assertive framing

Claims (20 extracted, 1 hedged)

- Published US Health Secretary Robert F Kennedy Jr. has released plans to loosen restrictions on controversial peptides. asserted
Jr. → publish → peptides
The plans, which were announced in the US Federal Register on Wednesday, say Kennedy would allow compounding pharmacies to prepare six popular peptides, which not been approved by the Food and Drug Administration (FDA). asserted
pharmacies → announce → Administration
In an unusual move, the draft came from the office of the health secretary rather than the FDA. asserted
draft → come → secretary
After the plan has been officially published later this week, there will be a two-week public comment period. asserted
plan → publish → ?
Unregulated injectable peptides have become popular online. asserted
peptides → become → ?
Experts have warned of their lack of clinical trials for humans and unknown long-term effects. asserted
Experts → warn → humans
The peptides mentioned in the plan include BPC-157, TB-500, KPV, MOTS-c and Semax. asserted
peptides → mention → BPC-157
Compounding pharmacies will be able to mix them to create medications. asserted
pharmacies → compound → medications
The BBC has contacted the FDA for comment. asserted
BBC → contact → comment
An FDA advisory panel voted in July to loosen restrictions on the six peptides. asserted
panel → vote → peptides
But FDA staff members recommended against it. asserted
members → recommend → it
Kennedy has described himself as a "big fan" of the drugs and has previously vowed to ease restrictions on them after the Biden administration clamped down on the growing industry. asserted
administration → describe → industry
Peptides are short chains of amino acids, or small proteins, which our bodies naturally produce. asserted
bodies → produce → which
They act as messengers, telling cells what to do, and play vital roles in skin health, immune system and hormone regulation. asserted
They → act → health
Peptides have been used to treat medical conditions for more than a century. asserted
Peptides → use → century
Insulin, one of the first peptide hormones to be discovered, helps people with Type 1 diabetes and some with Type 2 manage their blood sugar levels. asserted
people → discover → levels
But now unregulated peptides have exploded onto the wellness market since GLP-1s, weight loss drugs, became mainstream. asserted
GLP-1s → explode → market
Online influencers have been marketing peptides in what they have called "stacks" for unproven uses, claiming they can be used as a quick way to help people look younger, heal or improve their skin. asserted
people → market → skin
They have become popular among teens on TikTok, especially boys, over unproven claims they help to build muscle, part of online trends known as "biohacking" and "looksmaxxing". uncertain
they → become → biohacking
Health experts have cautioned against use of the drugs, citing a lack of clinical trials for humans and the unknown long-term effects of the substances. asserted
experts → caution → substances
Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

History Support